TY - JOUR
KW - asthma control
KW - asthma exacerbation
KW - biomarker
KW - eosinophilia
KW - phenotype
KW - type 2 inflammation
AU - T. Tran
AU - M. Kerkhof
AU - V. Carter
AU - D. Price
AD - Global Medicine Development, AstraZeneca, Gaithersburg, MD, USA.
Mescio Research, Blauwestad, the Netherlands.
Observational and Pragmatic Research Institute, Singapore.
Optimum Patient Care, Cambridge, UK.
Division of Applied Health Sciences, Centre of Academic Primary Care, University of Aberdeen, Aberdeen, UK.
AN - 34211281
BT - J Asthma Allergy
C2 - PMC8242130
DO - 10.2147/jaa.s306416
DP - NLM
ET - 2021/07/03
LA - eng
N1 - 1178-6965
Tran, Trung N
Kerkhof, Marjan
Carter, Victoria
Price, David B
Orcid: 0000-0002-9728-9992
Journal Article
J Asthma Allergy. 2021 Jun 25;14:727-742. doi: 10.2147/JAA.S306416. eCollection 2021.
PY - 2021
SN - 1178-6965 (Print)1178-6965
SP - 727
EP - 742
T2 - J Asthma Allergy
TI - Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study
VL - 14
ER -